Life sciences and biotech £86bn boost to science and tech in the UK to turbocharge economy £86bn to fund everything from new drug treatments and longer-lasting batteries to new AI breakthroughs to generate billions for the UK economy and drive our Plan for Change Latest Content Elsevier launches an AI tool to support faster and more reliable access to regulatory insights for drug development Qureight’s AI 3D imaging platform to support research on Idiopathic Pulmonary Fibrosis (IPF) Tackling real-world life science challenges with quantum computing New technologies Solution Accelerators for biotech research Merz consolidates its R&D with a Life Sciences platform White papers Centralising analytical data from mass spectrometry in drug discovery and development Discover how experts from Zoetis, Bayer, LifeMine Therapeutics, Iterion, Targenomix, and the Pistoia Alliance are solving key data challenges for mass spectrometry applications. Standardization of Analytical Data: Best Practices Standardization is critical to extracting the full potential of data. This White Paper offers a comprehensive guide to overcoming challenges and driving progress in analytical chemistry and beyond. Advancing the use of emerging computing infrastructure in Life Sciences RCH Solutions supports the adoption of novel computing technologies such as cloud, quantum, AI and edge computing paradigms through a co Webcasts On Demand Webinar: Consolidating computing resources can democratise research infrastructure More content Continued growth predicted for NGS Illumina and IDT Partnership to expedite exome enrichment Scientists use HPC to unearth new species in tropical rainforest soils The evidence of life's path Pagination Previous page ‹ Previous Page 16
